Both in Pharmaceuticals
Fulcrum Therapeutics vs Turn Therapeutics
Over the past year FULC returned −55.0% and TTRX returned +126.6%; their daily moves had a correlation of -0.10.
FULC −55.0% TTRX +126.6%Growth of $1, one year, split-adjusted
| Metric | FULC | TTRX |
|---|---|---|
| Price | $3.77 | $9.80 |
| Market cap | $288.0M | $297.6M |
| Today | +0.80% | +3.05% |
| 1 month | +2.2% | −15.8% |
| 6 months | −47.0% | +158.2% |
| Year to date | −66.7% | +148.7% |
| 1 year | −58.2% | +121.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $318.8M | $4.2M |
| Dividend yield | — | — |
| Volatility (60d) | 15.0% | 89.4% |
| Short % of float | 10.6% | 3.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).